Palantir Technologies (NASDAQ: PLTR) delivered a blowout Q2 2025 report, underscoring its position as one of the fastest-growing names in enterprise AI.
The company reported total revenue of $1.004 billion, up 48% year-over-year, with its U.S. commercial segment surging 93% YoY. Government growth remained strong as well, with a 14% sequential increase and a 53% YoY gain, bolstered by a $218 million U.S. Space Force contract and a 10-year Army agreement worth up to $10 billion. Reflecting its momentum, Palantir raised full-year revenue guidance to $4.142–$4.150 billion.
The stock is now on pace to open trading near a $400 billion market cap, a staggering shift that makes Palantir nearly double the size of UnitedHealth (NYSE: UNH), a company that was almost 10 times larger than Palantir just one year ago.
Wall Street sets PLTR stock price target
Wall Street responded swiftly. Deutsche Bank upgraded Palantir to Hold from Sell, doubling its price target to $160, citing the quarter’s “impressive revenue growth, expanding backlog, and margin improvement.”
Morgan Stanley’s Sanjit Singh also raised his target to $155 from $98, maintaining an Equal Weight rating and describing the results as “a wow moment,” with nearly every key metric accelerating from Q1’s already strong performance.
The combination of rapid commercial adoption, deepening government ties, and expanding AI use cases has positioned Palantir as one of the most closely watched names in the sector, and analysts see its ability to monetize AI deployment as a key driver for further upside.
